Prognostic Value of Soluble Death Receptor Ligands in Patients with Transitional Cell Carcinoma of Bladder-Reference-Cited by-同舟云学术

Prognostic Value of Soluble Death Receptor Ligands in Patients with Transitional Cell Carcinoma of Bladder

Published:2018 Issue:4 Volume:100 Page:476-484
ISSN:0042-1138
Container-title:Urologia Internationalis
language:en
Short-container-title:Urol Int

Author:

Ben Bahria-Sediki Islem,Chebil Mohamed,Sampaio Carla,Martel-Frachet Véronique,Cherif Mohamed,Zermani Rachida,Rammeh Soumaya,Ben Ammar Gaaied Amel,Bettaieb Ali

Publisher

S. Karger AG

Subject

Urology

Reference17 articles.

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. CA Cancer J Clin 2011; 61: 69–90.

2. Zeegers MP, Kellen E, Buntinx F, van den Brandt PA: The association between smoking, beverage consumption, diet and bladder cancer: a systematic literature review. World J Urol 2004; 21: 392–401.

3. Simoneau AR, Jones PA: Bladder cancer: the molecular progression to invasive disease. World J Urol 1994; 12: 89–95.

4. Babjuk M, Burger M, Zigeuner R, Shariat SF, Van Rhijn BW, Compérat E, Sylvester RJ, Kaasinen E, Böhle A, Palou Redorta J, Rouprêt M; European Association of Urology: EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013. Eur Urol 2013; 64: 639–653.

5. Whiteside TL: The role of death receptor ligands in shaping tumor microenvironment. Immunol Invest 2007; 36: 25–46.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of Prognostic Biomarkers for Bladder Cancer Based on DNA Methylation Profile;Frontiers in Cell and Developmental Biology;2022-01-31

2. Comparative quantitative assessment of serum soluble fas and fasl between urological tumor patients and healthy donors;PROCEEDING OF THE 1ST INTERNATIONAL CONFERENCE ON ADVANCED RESEARCH IN PURE AND APPLIED SCIENCE (ICARPAS2021): Third Annual Conference of Al-Muthanna University/College of Science;2022

3. Gene regulatory networks analysis of muscle-invasive bladder cancer subtypes using differential graphical model;BMC Genomics;2021-06